Skip to content
Credit reportVerdict and grounds
Made on 19-11-2026 at 04:17
Reference CK-0896696704-20261119

DR. DERVAUX

ActivePrivate limited company0896.696.704Karel Oomsstraat 22, 2018 Antwerp
Specialist medical practice (NACE 86220) · founded in 2008 · one director · accounts in the micro format

Sources: the KBO register on 19-11-2026; the National Bank, 2025 annual accounts filed on 24-09-2026; the Belgian Official Gazette, latest deed of 10-05-2023.

Credit verdict
Checked score 2025
The score, from 0 to 100, reflects the bankruptcy probability and the standing among sector peers.
Bankruptcy probability within 12 months
The median of 24,214 micro companies in the human health sector (NACE 86) is below 0.1%.
Gross margin
€302,643
▼ 5.0% against 2024
Net result
€203,994
▼ 4.5% against 2024
Equity
€1.0m
▲ 7.0% against 2024
Cash
€725,899
▲ 12.6% against 2024

Grounds

the facts the verdict rests on, each with its source
  1. DR. DERVAUX made a profit in every financial year since 2008.Annual accounts 2008 to 2025 page 2
  2. Equity stands at €1.0m, or 96.9% of the balance sheet total of €1.1m. That is more than 95% of the 21,349 companies in the human health sector (NACE 86).Annual accounts 2025 page 2
  3. DR. DERVAUX paid out €135,723 in dividends, 67% of the profit of 2025.Annual accounts 2025 page 2
  4. The 2025 accounts reached the National Bank on 24-09-2026, 55 days after the term.National Bank, filing of 24-09-2026 page 5

Representation

Checked did not find the signing rule in the deeds it read.

Ownership

Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.

DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 1 of 6
DR. DERVAUX0896.696.704 · report of 19-11-2026

Financial situation

Annual accounts 2021 to 2025, as filed with the National Bank

Gross margin and net resultin €m

20210.320220.220230.220240.320250.320210.220220.120230.220240.220250.2
gross marginnet result

Equity and debtsin €m

202120222023202420251.00.03
equitydebts

Cashin €m

20210.520220.520230.620240.620250.7
on the balance sheet date
Financial year20212022202320242025Trend
Results
Gross margin€312,264€213,708€245,931€318,690€302,643
Operating result€298,323€200,708€233,688€306,221€289,931
Net result€208,482€141,970€162,732€213,545€203,994
Balance sheet at the closing date
Equity€806,120€800,959€886,388€978,148€1.0m
Debts€55,456€53,603€27,593€48,131€33,709
Debts due within one year€55,456€53,603€27,593€48,131€33,709
Cash€475,700€527,968€563,167€644,639€725,899
Balance sheet total€861,576€854,561€913,981€1.0m€1.1m
Ratios
Solvency93.6%93.7%97.0%95.3%96.9%
Liquidity14.6715.2631.9920.8431.70

Source: Annual accounts 2025, micro format, filed on 24-09-2026 (2026-00525760); Annual accounts 2024, micro format, filed on 24-09-2025 (2025-00505445); Annual accounts 2021 to 2023, filed from 27-09-2022 to 30-09-2024 (2022-20445804, 2023-00470759, 2024-00491855).

Debts fell by €14,422 in 2025.

The 2025 annual accounts state no amount of overdue tax or social security (RSZ) debts.

DR. DERVAUX states no turnover; the micro format does not require it. The gross margin, what is left after purchases, fell from €318,690 to €302,643.

DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 2 of 6
DR. DERVAUX0896.696.704 · report of 19-11-2026

Board, signature and ownership

Position on 19-11-2026 according to the deeds in the Belgian Official Gazette and the annual accounts

Who represents the company

Checked did not find the signing rule in the deeds it read.

Board

one director in office
Managerappointed by deed of 19-12-2018
deed of 19-12-2018

Ownership and group

Shareholders

Accounts in the micro format list no shareholders. Checked found none in the deeds or the LEI register either.

Board changes

changes role from manager to director. Legal-form conversion: to private limited company. Director discharge: . General meeting of 03-05-2023.

Gazette, deed 23343315

appointed as manager. General meeting of 06-06-2017.

Gazette, deed 18181095
DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 3 of 6
DR. DERVAUX0896.696.704 · report of 19-11-2026

Holdings

DR. DERVAUX has 1 holding (own 2025 accounts).

Country Company Equity Result
Belgium 1
BE 25% €6,043 result €19

Source: List of holdings in its own 2025 accounts. Every holding stands with its own latest accounts.

DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 4 of 6
DR. DERVAUX0896.696.704 · report of 19-11-2026

Events and comparison

The last 24 months, newest first

Annual accounts 2025 filed, 55 days late.

NBB filing

Registered in the Peppol Directory. Reachable for e-invoices through 0208:0896696704.

Equity above €1m. Equity rises from €978,148 to €1.0m.

Financial

Annual accounts 2024 filed, 55 days late.

NBB filing

Highest result from 2008 to 2025. The operating result of €306,221 and the net result of €213,545 are both a record.

Financial

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as DR. DERVAUX has now: small, 10 to 20 years old, solvency 30% or more and a profit of 5% of the balance sheet or more. Two years later 96.5% were still trading, 3.2% had stopped another way and 0.3% had gone bankrupt.

still trading 96.5% stopped another way 3.2% bankrupt 0.3%

In 2025, DR. DERVAUX had a higher net result than 89% of the 21,334 companies in the human health sector (NACE 86).

Other findings

Peppol

Reachable for e-invoices since 27-03-2026, under 0208:0896696704.

Sanctions lists

DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 5 of 6
DR. DERVAUX0896.696.704 · report of 19-11-2026

Sources and method

Where each fact in this report comes from

SourceWhatDateReference
KBO registerRegistration, legal situation, activity, establishment units19-11-2026KBO 0896.696.704
National Bank of BelgiumAnnual accounts 2025, micro format24-09-20262026-00525760
National Bank of BelgiumAnnual accounts 2024, micro format24-09-20252025-00505445
National Bank of BelgiumAnnual accounts 2021 to 202327-09-2022 to 30-09-20242022-20445804, 2023-00470759, 2024-00491855
Belgian Official GazetteBoard10-05-2023deed 23343315
Belgian Official GazetteBoard19-12-2018deed 18181095
Peppol DirectoryRegistration for e-invoices27-03-20260208:0896696704
Sanctions lists EU, UN, US (OFAC) and UKComparison of the name16-11-2026no match
CheckedChecked score, bankruptcy probability, credit, comparable companies18-11-2026bankruptcy model of 2 October 2026

Method

Checked score. A number from 0 to 100. The bankruptcy probability sets the class, from Critical to Excellent; within the class, the comparison with sector peers on solvency, liquidity, profitability and growth counts for half.

Bankruptcy probability. The probability that the company goes bankrupt within 12 months, estimated from the KBO register, the annual accounts and the Gazette with the bankruptcy model of 2 October 2026, computed on 18-11-2026.

Credit. The credit is a tenth of equity, weighted by the score, and never more than a tenth of turnover. With negative equity there is no credit.

Payment terms. Supplier credit is the debt to suppliers divided by the year's purchases, times 365. Customer credit is the same for what customers still owe, against turnover.

Comparable companies. Companies of the same size, age, solvency and profitability at an earlier date, followed two years later in the KBO register and the Gazette.

The scores and ratios are Checked's own calculations, not a credit decision.

DR. DERVAUX · 0896.696.704 · credit report of 19-11-2026Page 6 of 6